Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics
PMID: 38581670
Source: Inflamm Bowel Dis
Publication date:
2025-07-24
Year:
2024
Abstract
NULL